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Abstract:  Neurological complications in orthotopic heart transplantation represent a major cause of morbidity and 
mortality despite successful transplantation. The most frequent perioperative neurological complications are delirium or 
encephalopathy. In this period cerebrovascular complication ranges between 5-11%. After the perioperative period, the 5-
year stroke risk after cardiac transplantation is 4.1%. In a retrospective study conducted with 314 patients who underwent 
cardiac transplantation, it was found that 20% of cerebrovascular complications occurred within the first two weeks after 
transplantation, while 80% occurred in the late postoperative phase. Of these, ischemic stroke is the most common 
subtype.  
In the perioperative periode, hemodynamic instability, cardiac arrest, extracorporeal circulation over 2 hours, prior history 
of stroke, and carotid stenosis greater than 50% have been reported to be risk factors for the occurrence of cerebrovascular 
complications. Perioperative cerebrovascular complications are associated with higher mortality and poor functional 
outcome at one year follow-up. 
After the perioperative period, the only factor that has been significantly associated with an increased risk of 
cerebrovascular complications is a history of prior stroke, either ischemic or hemorrhagic. Other associated factors include 
unknown atrial fibrillation, septic emboli from endocarditis, cardiac catheterization and perioperative hemodynamic 
shock. According to the TOAST etiologic classification, the most prevalent etiologic subtype of ischemic stroke is 
undetermined cause. 
INTRODUCTION 
  In recent decades, organ transplantation is a therapeutic 
alternative with excellent results in quality of life and 
survival. Cardiac transplantation is a currently accepted 
treatment for many patients with terminal heart disease. 
Since the first heart transplant performed by Bernard in 
1967, improvement in surgical techniques as well as 
immunosuppression has led to increasing survival rates up to 
80% in the first year, and 70% at 5 years [1]. For this reason, 
heart transplantation is an elective treatment for patients with 
advanced irreversible cardiopathies with no other feasible 
medical or surgical options.  
  However, cardiac transplantation is not without compli-
cations. The most common causes of mortality in cardiac 
transplantation are infections, graft vascular disease, sudden 
death, acute graft failure, tumours and acute rejection [1].  
  Neurological complications in orthotopic heart trans-
planttation represent a major cause of morbidity and 
mortality despite successful transplantation. The incidence 
and characteristics of neurological complications vary accor-
ding to studies, depending on whether they are diagnosed at 
autopsy or clinically in survivors. According to some reports, 
the incidence of neurological complications in patients with 
cardiac transplantation varies from 23% in the perioperative 
period [2] to 13% in the first month [3], and 18% in the first 
ten years after transplantation [4]. 
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 Table  1 shows the frequency of neurological compli-
cations in the perioperative period, from day 1 to 60 days 
after transplantation. Neurological complications in this 
period are influenced by the underlying disease, the surgical 
procedure and surgical or medical complications during 
postoperative course. According to published series, the most 
frequent perioperative neurological complications are deli-
rium or encephalopathy (9% of transplant patients in some 
series) [2]. Cerebrovascular complication during this period 
ranges between 5-11% [2, 4]. Of these, ischemic stroke is the 
most common subtype. 
Table 1.  Perioperative Neurological Complications 
Cerebrovascular Complications                                                       5-11% 
     Ischemic stroke 
     Hemorrhagic stroke 
     Post-anoxic encephalopathy 
     Transient Ischemic Attack 
Seizures                                                                                                2 % 
Peripheral neuropathy or myopathy                                                     4 % 
     Brachial plexopathy 
     Peroneal mononeuropathy 
     Vocal cord paralysis 
Delirium or encephalopathy                                                              2-9 % 
Reversible posterior leukoencephalopathy                                          1 % 
Progressive multifocal leukoencephalopathy                                      1 % 
Herpes Zoster Radiculopathy                                                               2 % 
Cryptosporidium Meningitis                                                                1 % Cerebrovascular Complications After Heart Transplantation    Current Cardiology Reviews, 2010, Vol. 6, No. 3    215 
 Table  2 shows the frequency of neurological compli-
cations after the perioperative period which may occur in up 
to 72% of recipients in long term follow-up [2]. Due to 
neurologic complications, mortality is 8% of patients during 
the first year and 12% of survivors suffer a moderate func-
tional dependence. Despite this, 80% of patients who suffer 
neurological complications after cardiac transplantation have 
a good functional outcome in the first year [2]. 
Table 2.  Neurological Complications After the Perioperative 
Period 
Cerebrovascular diseases                                                                   9 %  
Seizures                                                                                              4 % 
Polyneuropathy                                                                                 18 %  
Sleeping disorders                                                                             27 % 
Cognitive empairment                                                                          6 % 
Pain                                                                                                     30 % 
Depression                                                                                          28 % 
Cerebrovascular Complications 
  A retrospective review of 314 patients who underwent 
cardiac transplantation showed that 20% of cerebrovascular 
complications occurred within the first two weeks after 
transplantation, while 80% occurred after this period [5]. 
  The most common cerebrovascular complication is ische-
mic stroke. Other cerebrovascular complications reported 
include transient ischemic attack (TIA), hemorrhagic stroke, 
anoxic encephalopathy, hyperperfusion syndrome or cogni-
tive impairment of vascular etiology (Table 3). 
Table 3.  Type of Cerebrovascular Complications 
Ischemic stroke                                                                             60 %  
TIA                                                                                                28 % 
Hemorrhagic stroke                                                                       12 % 
Hypoxic encephalopathy                                                                 1 % 
Hyperperfusion syndrome                                                               - 
Vascular cognitive impairment                                                        - 
 
  It has been suggested that the etiology of heart disease 
leading to transplantation could be related to the risk of post 
transplantation cerebrovascular complications. In some 
studies, dilated cardiomyopathy, ischemic cardiomyopathy, 
and valvular heart disease were found to be the most 
frequent etiologies implicated [3, 4]. However, other studies 
did not found this association [5]. Unexpectedly, established 
risk factors of stroke such as history of atrial fibrillation or 
presence of intracardiac thrombus were not related to the 
incidence of post transplantation cerebrovascular compli-
cations [6]. 
  The only vascular risk factor associated with an increased 
risk of cerebrovascular complications after heart transplan-
tation is the history of previous ischemic or hemorrhagic 
stroke [5]. In the following sections we review these 
cerebrovascular complications in two different periods: the 
perioperative period and the long-term follow-up period. 
Intraoperative and Perioperative Period 
  Cerebrovascular complications occurring within the 
intraoperative and postoperative period are associated with 
high mortality in the first year after transplantation. Different 
factors may play an important role in the development of 
cerebrovascular complications in this period and therefore 
the etiology of cerebrovascular complications is often 
multifactorial (asystole, cardiac trauma, gaseous embolism, 
fat embolism, aortic or cardiac embolism, global ischemia, 
coagulation disorders, infections) [5, 7]. 
  Hemodynamic instability, cardiac arrest [6], extra-
corporeal circulation over 2 hours [8], prior history of stroke, 
and carotid stenosis greater than 50% [9] have been reported 
to be decisive for the appearance of cerebrovascular com-
plications [6]. Clamping and manipulation of the ascending 
aorta and the type of surgical technique (standard versus 
bicava) have been also associated with higher risk of 
cerebrovascular events, but without statistical significance.  
  Within the intraoperative period, global cerebral hypoxia 
may occur due to intraoperative complications such as right 
heart failure or ventricular laceration. Both ischemic and 
hemorrhagic stroke are associated with aortic embolism due 
to handling, incomplete reversal of antiplatelet/anticoagulant 
treatment, and elevated pressure in the cardiopulmonary 
bypass [7]. 
  Ventricular assist devices are another important risk 
factor for cerebrovascular events. In a prospective study, up 
to 66% of cerebrovascular complications occurred within 4 
months after implantation of the device. The stroke risk is 
greater with longer ventricular assist device support period. 
On the other hand, it has been reported that 42% of strokes 
occur in patients with concomitant infections presumably 
due to platelet activation which predisposes to stroke. 
Selection of ventricular assistance, infection prevention and 
strict control of anticoagulation in these cases can prevent 
these complications [10]. 
  In this period, patients who undergo cardiac catheteri-
zation must be taken into account, as these represent an 
estimated rate 8.3% of strokes events [5, 6].  
  Moreover, disseminated intravascular coagulopathy 
(DIC) may occur during this period. DIC has been diagnosed 
in patients with sepsis caused by various microorganisms 
after heart transplantation. These patients are at an added risk 
of cerebral parenchymal haemorrhage and subdural hema-
tomas [7] 
  Another cerebrovascular complication is the hyper-
perfusion syndrome. In patients with chronic cardiac pump 
failure, a reduction of cerebral blood flow has been described 
in transcranial Doppler and SPECT studies. These alterations 
in brain perfusion can rapidly normalize in patients follow-
ing cardiac transplantation. In a study by Massaro et al. the 
mean blood flow velocity of the middle cerebral artery and 
the pulsatility index was measured by transcranial Doppler. 
In the Preoperative period, patients had a mean flow velocity 
of the middle cerebral artery of 45.1 cm/sec and a Pulsatility 
Index (PI) of 0.98. In successfully transplanted patients, the 
mean velocity increased by 53.3% (p<0.0001) and mean PI 
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in most patients before the transplant as a possible marker of 
refractory heart failure, normalized afterwards. Some of the 
patients that showed a rapid increase of the flow velocity 
presented symptoms suggestive of hyperperfusion syndrome 
consisting of severe headache, nausea, vomiting and 
decreased level of consciousness. Thus, the rapid impro-
vement of cardiac function after transplantation may be the 
cause of the hyperperfusion syndrome [11]. 
Follow-Up of the Transplanted Patient 
  Ischemic stroke is the most prevalent cerebrovascular 
complication during the follow-up after heart transplantation. 
After the perioperative period, the only factor that has been 
significantly associated with an increased risk of cerebro-
vascular complications is a history of prior stroke, either 
ischemic or hemorrhagic [5]. No increased risk of cerebro-
vascular complications was found in patients with atrial 
fibrillation, anemia, hypotension or hypertension and cardiac 
pump failure.  
  In the report by Belvis et al. [5], it was found that the 
most frequent clinical syndrome, according to the 
classification of the Oxfordshire Community Stroke Project, 
was the partial anterior circulation syndrome (Table 4). 
Table 4.  Oxfordshire Classification 
Total Anterior Cerebral Infarction                                                  23,1 % 
Partial Anterior Cerebral Infarction                                               38,4 % 
Lacunar Cerebral Infarction                                                          15,4 % 
Posterior Cerebral Infarction                                                         23,1 % 
 
  Stroke of undetermined cause, according to the TOAST 
etiologic classification, is the most prevalent etiologic sub-
type of ischemic stroke (Table 5). In Belvis’s et al. report, 
unknown atrial fibrillation was the cause of all cardio-
embolic strokes, while septic emboli in bacterial endocarditis 
was identified as a causal factor in other reports [5, 7]. 
Table 5.  TOAST Etiologic Classification 
Large artery atherosclerosis                                                           15,4 %  
Cardioembolism                                                                            14,4 %  
Small vessel disease                                                                      15,4 %  
Unusual causes                                                                              15,4 % 
Undetermined cause                                                                       38,4 % 
 
  The unusual etiology ischemic strokes were caused by 
cardiac catheterization and perioperative hemodynamic 
shock [5].  
  TIA is the second most common cerebrovascular compli-
cation. TIA after heart transplantation has not been asso-
ciated with any cause or predisposing factor. 
  On the other hand, hemorrhagic stroke is an unusual 
cause of cerebrovascular disease after heart transplantation. 
In some studies hemorrhagic stroke has not been observed as 
a cerebrovascular complication outside perioperatory period.  
 
However, in other studies, it has been described as the cause 
of up to 12 % of cerebrovascular complications. A history of 
previous hemorrhagic stroke has been associated with an 
increased the risk of cerebral bleeding complication [5]. 
Furthermore, patients who present a TIA have a higher risk 
of hemorrhagic stroke in the follow-up [5]. 
  In patients with a history of pre-transplant ischemic or 
hemorrhagic stroke, the 5-year stroke risk after cardiac 
transplantation, is 4.1%, which is significantly higher than in 
non-transplanted patients [5]. 
  Immunosuppressive treatment is an additional factor that 
can be responsible of neurological complications after 
cardiac transplantation. It is difficult to evaluate the relation-
ship between risk of ischemic stroke and immunosuppressive 
drugs, because there are numerous drug combinations in the 
immunosuppressive regimen.  
  Sirolimus is a potent immunosuppressive drug that often 
is part of the immunosuppressive regimen in heart transplant 
patients. Sirolimus as a part of combined immunosupp-
ressive regimen has been identified as a potential cause of 
thrombotic microangiopathy. Frequent neurological compli-
cations associated with Sirolimus include polyneuropathy, 
tremor and ischemic stroke, bleeding and TIA. 
  However in a study by Diederik et al. [12], patients who 
suffered cerebrovascular complications after cardiac trans-
plantation were not under treatment with Sirolimus. Based 
on this observation, the authors speculated that Sirolimus-
based immunosuppressive therapy may prevent cerebro-
vascular complications. However more studies are needed to 
confirm this hypothesis.  
CONCLUSION 
  Neurologic complications after cardiac transplantation 
are a major cause of morbidity. Among neurological com-
plications, cerebrovascular disease occurs more frequently 
after the perioperative period, and the most common type is 
ischemic stroke. There is no clear relationship between the 
specific heart disease that lead to transplantation and 
cerebrovascular complications. However, it is well known 
that a previous history of stroke is an important risk factor to 
suffer a recurrent stroke after transplantation. The most 
common etiologic stroke subtype is undetermined, as in 
stroke that affects non-transplanted patients.  
  When cerebrovascular complications occur in the 
perioperative period, a high mortality within the first year 
has been described. A proper selection of the patient and the 
assessment of the most appropriate surgical technique are 
very important. It is also essential to have a good neuro-
logical evaluation after anaesthesia because some focal 
cerebrovascular diseases are undiagnosed, and should be 
treated as soon as possible. 
  In conclusion we must keep in mind the importance of 
cerebrovascular complications in transplanted patients. In 
addition to the mortality associated with these events, there 
is also the risk of poor functional outcome in 12% of patients 
at the 1-year follow-up. 
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